awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37119406-5976B45A-674E-4901-81BE-5F71D78312BA
Q37119406-5976B45A-674E-4901-81BE-5F71D78312BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37119406-5976B45A-674E-4901-81BE-5F71D78312BA
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study
P2860
Q37119406-5976B45A-674E-4901-81BE-5F71D78312BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37119406-5976B45A-674E-4901-81BE-5F71D78312BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7eab98ce080d49ce91a6293ce3f2fd16380c1db
P2860
Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers.